Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare two different medications used to reduce pain
during lower back fusion surgery. The main questions this study aims to answer are:
1. Can liposomal bupivacaine, when included in a regional anesthesia technique called the
Erector Spinae Plane block (ESPB), reduce opioid use post-operatively compared to the
standard medication typically used in an ESPB (bupivacaine with stabilizing agents)?
2. Do patients report lower pain and better satisfaction with their surgery when they
receive liposomal bupivacaine in the ESPB compared to those that receive the standard
medication?
Participants will be randomized to into two groups one that receives liposomal bupivacaine
and one group that receives bupivacaine with stabilizing agents. Other than the randomization
all patients will follow current standard of care at our hospital, and will not be asked to
complete any additional study forms in addition to forms currently asked of all patients as
per standard of care.